Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining...
Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the...
Bombardier's new CEO is expected to be on the hot seat next week as he meets for the first time with shareholders who are clamouring for a turnaround plan after enduring a rough year by the...
RSS